EUVIMEDEUVIMED entdecken
EditorialOpen Access

China’s Pharmaceutical Ascent: Opportunity for Global Health, Test for US Leadership

Arya Babul, Parisa Mahdavi, Momina Hussain, Najib Babul

Cureus · 17.03.2026

DOI: 10.7759/cureus.105407 ↗

Kurz gefasst

Editorial in der Zeitschrift Cureus, erschienen am 17.03.2026. Verfasst von Arya Babul und 3 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Sciences, Society for Awareness of Neglected Diseases, Las Vegas, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

ai‑enabled drug discoverychina pharmaceutical innovationfda regulatory policyglobal drug developmentnmpaout‑licensingpharmaceutical regulationpublic health policyregulatory harmonizationus-china relationship

Autor:innen und Institutionen

  • Biomedical Sciences, Society for Awareness of Neglected Diseases, Las Vegas, USA.
  • Biomedical Sciences, West Career and Technical Academy, Las Vegas, USA.
  • Drug Development, Tavolar LLC, Las Vegas, USA.
  • Genomics, Chinese Academy of Tropical Agricultural Sciences, Sanya, CHN.
  • Drug Development, Quadra Therapeutics, Las Vegas, USA.

Zitieren

APA

Babul, A., Mahdavi, P., Hussain, M., & Babul, N. (2026). China’s Pharmaceutical Ascent: Opportunity for Global Health, Test for US Leadership. Cureus. https://doi.org/10.7759/cureus.105407

Vancouver

Babul A, Mahdavi P, Hussain M, Babul N. China’s Pharmaceutical Ascent: Opportunity for Global Health, Test for US Leadership. Cureus. 2026. doi:10.7759/cureus.105407

BibTeX
@article{Babul2026,
  author = {Babul, Arya and Mahdavi, Parisa and Hussain, Momina and Babul, Najib},
  title = {China’s Pharmaceutical Ascent: Opportunity for Global Health, Test for US Leadership},
  journal = {Cureus},
  year = {2026},
  doi = {10.7759/cureus.105407}
}
Kostenlos starten →